Literature DB >> 8763437

Mycobacterium ulcerans infection (Buruli ulcer): first reported patients in Togo.

W M Meyers1, N Tignokpa, G B Priuli, F Portaels.   

Abstract

Mycobacterium ulcerans infection (Buruli ulcer) is the third most common mycobacterial infection of immunocompetent humans, and is an emerging disease in West Africa. We describe the first two reported patients with Buruli ulcer in Togo, establishing a geographical continuum of the disease in all countries bordering the Gulf of Guinea. The aetiological agent was identified by molecular biological analysis of biopsy material. We speculate that changing environmental factors related to human habitation may influence rates of incidence of Buruli ulcer.

Entities:  

Mesh:

Year:  1996        PMID: 8763437

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  23 in total

Review 1.  Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?

Authors:  Paul J Converse; Eric L Nuermberger; Deepak V Almeida; Jacques H Grosset
Journal:  Future Microbiol       Date:  2011-10       Impact factor: 3.165

2.  Functional Diversity as a New Framework for Understanding the Ecology of an Emerging Generalist Pathogen.

Authors:  Aaron Morris; Jean-François Guégan; M Eric Benbow; Heather Williamson; Pamela L C Small; Charles Quaye; Daniel Boakye; Richard W Merritt; Rodolphe E Gozlan
Journal:  Ecohealth       Date:  2016-06-29       Impact factor: 3.184

3.  Comparison of two PCRs for detection of Mycobacterium ulcerans.

Authors:  A Guimaraes-Peres; F Portaels; P de Rijk; K Fissette; S R Pattyn; J van Vooren; P Fonteyne
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

4.  Prophylactic effect of mycobacterium bovis BCG vaccination against osteomyelitis in children with Mycobacterium ulcerans disease (Buruli Ulcer).

Authors:  F Portaels; J Aguiar; M Debacker; C Steunou; C Zinsou; A Guédénon; W M Meyers
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

Review 5.  Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans.

Authors:  Dezemon Zingue; Amar Bouam; Roger B D Tian; Michel Drancourt
Journal:  Clin Microbiol Rev       Date:  2017-12-13       Impact factor: 26.132

6.  Differentiation of Mycobacterium ulcerans, M. marinum, and M. haemophilum: mapping of their relationships to M. tuberculosis by fatty acid profile analysis, DNA-DNA hybridization, and 16S rRNA gene sequence analysis.

Authors:  T Tønjum; D B Welty; E Jantzen; P L Small
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

7.  Identification of Mycobacterium ulcerans in the environment from regions in Southeast Australia in which it is endemic with sequence capture-PCR.

Authors:  T Stinear; J K Davies; G A Jenkin; J A Hayman; F Oppedisano; P D Johnson
Journal:  Appl Environ Microbiol       Date:  2000-08       Impact factor: 4.792

8.  Dry-reagent-based PCR as a novel tool for laboratory confirmation of clinically diagnosed Mycobacterium ulcerans-associated disease in areas in the tropics where M. ulcerans is endemic.

Authors:  V Siegmund; O Adjei; P Racz; C Berberich; E Klutse; F van Vloten; T Kruppa; B Fleischer; G Bretzel
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

9.  Findings from a buruli ulcer mouse model study.

Authors:  P Addo; E Owusu; B Adu-Addai; M Quartey; M Abbas; A Dodoo; D Ofori-Adjei
Journal:  Ghana Med J       Date:  2005-09

10.  Immunoglobulin M antibody responses to Mycobacterium ulcerans allow discrimination between cases of active Buruli ulcer disease and matched family controls in areas where the disease is endemic.

Authors:  Daniel M N Okenu; Lazarus O Ofielu; Kirk A Easley; Jeannette Guarner; Ellen A Spotts Whitney; Pratima L Raghunathan; Ymkje Stienstra; Kwame Asamoa; Tjip S van der Werf; Winette T A van der Graaf; Jordan W Tappero; David A Ashford; C Harold King
Journal:  Clin Diagn Lab Immunol       Date:  2004-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.